It is a pharma private limited company based in Ernakulam, Kerala, India, established in 2002.
2002 | Ernakulam, Kerala, India | ActiveMarquess Genetica Pharmaceuticals Private Limited, a active private limited company, was established on 14 January 2002 in Ernakulam, Kerala, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U51397KL2002PTC015180. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Its leadership includes Rajumon Vilanganpara Mathew (Managing Director), Raveendran (Whole-Time Director), Wilson Liju (Whole-Time Director). Past directors included Albert Cherukunnel Mathew, Francis Xavier Jacob, Sajeev Madhavan Pillai. It holds ₹2.45 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 40/8080Sha Complex 3Rd Floor Mullassery Canal Road, Ernakulam, Kerala, 682011.
U51397KL2002PTC015180
015180
14 January 2002
₹1.00 M
₹1.00 M
Roc Ernakulam
Unlisted
Active
Explore comprehensive insights into Marquess Genetica Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajumon Vilanganpara Mathew | Managing Director | 01 Jun 2013 | Current |
| Raveendran | Whole-Time Director | 25 Mar 2014 | Current |
| Wilson Liju | Whole-Time Director | 25 Mar 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Jun 2013 | Past |
| Pramod Abcsdd | Whole-Time Director | 27 Jan 2016 | Past |
| Pramod Abcsdd | Director | 12 Sep 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Marquess Genetica Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 39.41% decrease. The company also saw a substantial improvement in profitability, with a 102.57% increase in profit. The company's net worth moved up by a moderate rise of 0.64%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Marquess Genetica Pharmaceuticals had a promoter holding of 72.00% and a public holding of 28.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹2,450,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Dec 2021 | Canara Bank | ₹0.20 M | Open |
| 26 Jun 2020 | Canara Bank | ₹0.25 M | Open |
| 27 Apr 2017 | Canara Bank | ₹2.00 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Marquess Genetica Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Marquess Genetica Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Marquess Genetica Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Marquess Genetica Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Marquess Genetica Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam. was documented.
A charge with Canara Bank amounted to Rs. 0.20 M with Charge ID 100541402 was registered on 31 Dec 2021. was recorded as a recent event.
Progress on A charge with Canara Bank amounted to Rs. 0.25 M with Charge ID 100369197 was registered on 26 Jun 2020. was documented.
Progress on A charge with Canara Bank of Rs. 2.00 M registered on 27 Apr 2017 with Charge ID 100114640 was modified on 06 Dec 2019. was documented.
Progress on A charge with Canara Bank amounted to Rs. 2.00 M with Charge ID 100114640 was registered on 27 Apr 2017. was documented.
The CIN of Marquess Genetica Pharmaceuticals Private Limited is U51397KL2002PTC015180.
Marquess Genetica Pharmaceuticals Private Limited is headquartered at 40/8080Sha Complex 3Rd Floor Mullassery Canal Road, Ernakulam, Kerala, 682011.
Marquess Genetica Pharmaceuticals Private Limited was incorporated on 14 January 2002.
The current directors of Marquess Genetica Pharmaceuticals Private Limited are
The primary industry of Marquess Genetica Pharmaceuticals Private Limited is Pharma.
Marquess Genetica Pharmaceuticals Private Limited is unlisted.
The authorized capital of Marquess Genetica Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Marquess Genetica Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX